Article
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.
Annals of hepatology - 1 Jan 2000
Yoshida Eric M, Kwo Paul, Agarwal Kosh, Duvoux Christophe, Durand François, Peck-Radosavljevic Markus, Lilly Leslie, Willems Bernard, Vargas Hugo, Kumar Princy, Brown Robert S, Horsmans Yves, De-Oertel Shampa, Arterburn Sarah, Dvory-Sobol Hadas, Brainard Diana M, McHutchison John G, Terrault Norah, Rizzetto Mario, Müllhaupt Beat
Abstract excerpt
INTRODUCTION: Recurrence of HCV infection in patients with chronic hepatitis C virus (HCV) at the time of liver transplantation is nearly universal and reduces the likelihood of graft and patient survival. MATERIALS AND METHODS: We evaluated outcomes of 17 patients (16 with HCV genotype 1 and 1 with genotype 4) who received up to 12 or 24 weeks of ledipasvir/sofosbuvir plus ribavirin prior to or up to the time of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.